Polaryx Therapeutics, Inc.
PLYX·NasdaqCM·Healthcare
1.8000+0.0700 (+4.05%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close1.7300
Open1.7900
Day range1.76011.8400
52-week range1.690048.9100
Off day high−2.17%
Off 52-week high−96.32%
Volume11.12K
Avg. volume (3M)54.55K
Market cap89.72M
EPS (TTM)-0.1400
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding49.85M
Short interest0.55% of float
Earnings date—
Analyst target7.5000
Profit margin0.00%
Against its peers
Compare in full ›| PLYX | ACTI.ST | INO | PYPD | ONCY | ANIX | |
|---|---|---|---|---|---|---|
| Market cap | 89.72M | 101.49M | 167.50M | 118.21M | 55.70M | 114.03M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | — | -3.9 | -5.6 | -2.1 | -10.6 |
| Price/book | 8.2 | 2.7 | 30.6 | 22.0 | -8.7 | 7.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −95.06% | −34.67% | −27.51% | +44.06% | −61.39% | −24.82% |
| Today | +4.05% | +4.62% | −2.41% | +6.59% | +8.92% | +7.36% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All PLYX news ›Polaryx Therapeutics: Interview With CEO Alex Yang About Developing Treatments For Rare Pediatric Lysosomal Storage Disorders
When asked about his background, Yang shared: I have more than 25 years of experience spanning law, finance, private equity, and biopharmaceutical leadership. I have served as Chair of Polaryx since June 2021 and Chief Executive Officer…
From the 4Search news index, newest first.
In the news
1mentions in 30 days
1with it in the headline
Mixedsentiment
Mentioned with
People in the coverage
Most coverage from
- pulse2.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.